Science advancesJul 1, 2026

Movable lipids create mechanical movements that help mRNA medicines enter cells better by breaking internal barriers

mRNA Technology Weekly Brief ↗PubMed ↗DOI ↗

Updated Jul 2, 2026

Abstract

Programmable mechanical movement in lipid nanoparticles (LNPs) may enhance mRNA vaccine efficacy.

Lipid nanoparticles are composed of ionizable lipids, phospholipids, cholesterol, and PEGylated lipids.
Endosomal entrapment is a critical bottleneck limiting the effectiveness of mRNA vaccines.
Previous optimizations of lipid properties show diminishing returns in improving vaccine efficacy.
Incorporating a light-emitting diode (LED)-driven movable lipid into LNPs may allow for destabilization of endosomal membranes.
Movable lipids function as molecular rotors under LED irradiation, facilitating endosomal escape.
Preclinical results indicate improved efficacy of mRNA-LNP cancer vaccines using this strategy.

Simplified

Lipid nanoparticles (LNPs), composed of ionizable lipids, phospholipids, cholesterol, and PEGylated lipids, have been successfully used in messenger RNA (mRNA) vaccine development. Despite substantial progress, endosomal entrapment after cellular internalization is still a critical bottleneck limiting the vaccine efficacy. While the efforts to optimize lipid pK_a, spatial conformation, and LNP composition have been made, further fine-tuning of these parameters shows diminishing returns in improving effectiveness. Here, we propose a previously unreported parameter, programmable mechanical movement. LNPs are expected to destabilize endosomal membranes through conducting mechanical movements under specific inputs, achieving robust endosomal escape. Specifically, we demonstrate a light-emitting diode (LED)-driven movable lipid (i.e., phenylazothiazole lipid) capable of performing mechanical movements. We integrate the movable lipids into the BNT162b2 formulation from Pfizer-BioNTech. Upon LED irradiation, the movable lipids within LNPs function as molecular rotors, thereby facilitating endosomal membrane destabilization. This strategy has achieved exciting preclinical results in enhancing mRNA-LNP cancer vaccine efficacy.